A 53-year-old woman presented with blood tinged sputum. She was a never-smoker and had a history of diabetes on medication. Chest computed tomography scan revealed endobronchial obstructive lesion in right bronchus intermedius (
Figure 1A). Bronchoscopic examination showed lobulated mass in endobronchial lesion (
Figure 1B), and bronchoscopic biopsy for mass was performed. Preoperative positron emission tomography-computed tomography revealed multiple fluorodeoxyglucose uptake in right bronchus intermedius and lymph nodes in right paratracheal area (
Figure 1C). On biopsy specimen, subepithelial infiltrating nests of atypical cells were identified, and differential diagnoses were neuroendocrine carcinoma such as carcinoid and poorly differentiated nonsmall cell carcinoma (
Figure 2A). Subsequent biolobectomy of right middle lobe and right lower lobe with mediastinal lymph node dissection was performed.
On cut section, a 2.2-cm-sized endobronchial polypoid mass was identified (
Figure 2B). The yellow-tan, solid mass was relatively well-defined, but focal interruption of bronchial cartilage was found. Microscopically, central area of the mass was composed of variable sized solid lobules of tumor cells. Tumor cells were evenly distributed in solid lobules, and central necrosis was found in the lobules. Nuclei of tumor cells showed moderate atypia and cytoplasm was eosinophilic and partly granular (
Figure 2C). At the periphery, transition from small infiltrating duct-like structures to solid lobules were identified (
Figure 2D). These duct-like structures resembled bronchial submucosal glands but showed nuclear atypia and infiltrative growth into peribronchial soft tissue, which were typical features of EMC. Due to the solid lobular area, differential diagnoses included collision tumor with EMC component such as metastatic lobular breast cancer, carcinoid, lymphoma, and pulmonary adenocarcinoma with solid pattern. To make final diagnosis, immunohistochemical stainings for thyroid transcription factor 1 (TTF-1; 1:100, 8G7G3/1, Dako, Carpinteria, CA, USA), p63 (1:200, 4A4, Biocare Medical, Concord, CA, USA), cytokeratin (CK; 1:500, AE1/AE3, Dako), chromogranin A (1:400, DAK-A3, Dako), CD56 (1:200, CD564, Novocastra, Newcastle upon Tyne, UK), smooth muscle actin (SMA; 1:1,000, 1A4, Dako), and Ki-67 (1:300, MIB1, Dako) were performed. Tumor cells were positive for CK (AE1/AE3) and SMA, whereas negative for remaining TTF-1, p63, chromogranin A, and CD56. In solid area, CK (AE1/AE3) was positive in inner center of the lobules and SMA was positive in the outer layer of the lobules. Peripheral duct-like structures also showed CK (AE1/AE3) positive cells in inner layer, and SMA positive cells in outer layer (
Figure 2E, F). S-100 protein highlighted myoepithelial component of the peripheral duct-like structure, whereas only focal area of positivity was found in the solid lobules (
Figure 2G). Ki-67 revealed high proliferative index in outer area of solid lobules, up to 40%. However, the center of solid lobules and adjacent duct-like structure showed less than 1% of proliferative index (
Figure 2H). Finally, diagnosis of poorly differentiated EMC was rendered. Since there were metastases in right hilar and subcarinal lymph nodes, patient underwent adjuvant chemotherapy.